$CAI

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (1y)
Win rate (1y)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$CAISEC Form 4bearish
Sold 597,212 @ $24.84 avg · $14,834,107 · 2026-09-03

Form 4: Spetzler David Baxley sold CAI

Spetzler David Baxley (President at Caris Life Sciences, Inc.) reported an open-market sale of 597,212 shares of CAI at an average $24.84, roughly $14,834,107, in a Form 4 filed 2026-09-04.

View filing on SEC.gov →

End of results.